4.2 Pentamidine Administration
Pneumocystis jirovecii pneumonia (PJP, formerly PCP) is a severe and preventable complication of immune-suppressing therapy. While most pediatric oncology patients receive cotrimoxazole (Septra, sulfamethoxazole and trimethoprim) as PJP prophylaxis, not all will tolerate it and require alternative therapy. Pentamidine is a primary alternative, given inhaled or intravenously.
The information provided in the following sections (Sub-Section 4.2.1 Inhaled Pentamidine; Sub-Section 4.2.2 Intravenous Pentamidine) is intended to guide safe practice in the POGO Satellite Clinics. It is not intended to replace your institutional policies and procedures. Please ensure all staff are aware of their own institutional policies and procedures and refer to them as their primary source.
Disclaimer: Source Accuracy
You are welcome to download and save a local copy of this document in the Word and/or PDF formats provided. As the POGO Satellite Manual is subject to ongoing revisions and updates by POGO, we recommend you regularly check the online version posted at https://www.pogo.ca/satellite-manual/ to ensure you have the most up-to-date content. In the event of any inconsistency between the content of a local copy and the online version of the POGO Satellite Manual, the content of the online version shall be considered correct. Please see also the POGO Satellite Manual Disclaimer.
Record of Updates
|Version Number||Date of Effect||Summary of Revisions|
|1||1/28/2022||Original version posted.|